儿童特应性皮炎中丝聚蛋白功能缺失变异与种族的关联
该研究基于美国儿童湿疹登记库的前瞻性队列,对741例轻中度特应性皮炎患儿进行FLG基因功能缺失变异测序。白人患儿携带任何FLG LoF变异的比值比为2.44(95%CI 1.76-3.39),且FLG LoF与AD持续存在的比值比为0.67(95%CI 0.56-0.80)。结论提示常规检测4个常见变异不充分,基因检测应覆盖不同种族的变异。
要点
- 白人AD患儿FLG LoF变异携带率高于非裔美国患儿,OR=2.44。
- 部分FLG LoF变异仅见于特定种族,如p.S3316*和p.R826*未在白人中出现。
- 携带FLG LoF的患儿AD更易持续,OR=0.67。
核心结论
- 美国轻中度AD患儿中FLG LoF变异因种族而异,且与AD持续存在相关。
- 常规检测4个常见FLG变异不足以全面评估AD遗传风险。
研究设计与样本
- 前瞻性美国队列研究,纳入儿童湿疹 elective registry(PEER)遗传亚组。
- 共741例轻中度AD患儿,平均发病年龄1.97(SD 2.72)岁。
- 采用大规模平行测序(MPS)靶向检测FLG LoF变异。
主要发现
- 全队列FLG LoF变异携带率为23.9%(177/741),白人为31.5%(124/394),非裔美国人为15.3%(50/326)。
- 白人患儿携带任何FLG LoF变异相比非裔美国患儿的OR为2.44(95%CI 1.76-3.39)。
- 携带FLG LoF与AD持续存在的OR为0.67(95%CI 0.56-0.80)。
- 发现23个FLG LoF变异,部分变异仅见于特定种族。
临床怎么用
- 临床进行AD遗传检测时应覆盖多种族特异性FLG LoF变异,而非仅检测4个常见变异。
- 对白人AD患儿可考虑FLG LoF检测以评估持续风险,但需注意种族差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Atopic dermatitis (AD) is a common chronic illness that has been associated with variation in the filaggrin gene (FLG). Four variants are most often evaluated. OBJECTIVES: To comprehensively describe and compare results from targeted sequencing of FLG loss-of-function (LoF) variants in children of African and European ancestry and the association of these variants with onset and persistence of AD. DESIGN, SETTING, AND PARTICIPANTS: This prospective US cohort study assessed the genetic subcohort of the Pediatric Eczema Elective Registry (PEER). Children with mild to moderate AD were included in the analysis. Massively parallel sequencing (MPS) was used to focus on FLG LoF variation in white and African American children. Patients were enrolled from June 2005 through July 2017. Data were analyzed from January 25 through May 10, 2019. MAIN OUTCOMES AND MEASURES: Associations of FLG LoF variation with white and African American ancestry and with the risk and persistence of AD. RESULTS: A total of 741 children were included in the analysis (394 [53.2%] female and 347 [46.8%] male; mean [SD] age at onset, 1.97 [2.72] years); of these, 394 (53.2%) were white, 326 (44.0%) were African American, and 21 (2.8%) were of other ancestries. Using MPS technology, 23 FLG LoF variants were found in children with AD. The prevalence of FLG LoF variants was 177 participants (23.9%) in the full cohort, 124 white participants (31.5%), and 50 African American participants (15.3%). The odds ratio for carrying any FLG LoF variant in a white child compared with an African American child with AD was 2.44 (95% CI, 1.76-3.39). Some FLG LoF variants are only found in children of a specific ancestry (eg, p.S3316* and p.R826* were not seen in white patients). Children with an FLG LoF were more likely to have persistent AD (odds ratio, 0.67; 95% CI, 0.56-0.80). CONCLUSIONS AND RELEVANCE: The FLG LoF variants in a US cohort of children with mild to moderate AD differ significantly by race and their association with the persistence of AD. Conventional testing of the 4 frequently evaluated variants is inadequate. Any planned genetic diagnostic test for AD based on FLG LoF variants must be inclusive and not rely on the most frequently studied variants.
引用
- Margolis DJ, Mitra N, Wubbenhorst B, et al. Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis. JAMA Dermatol. 2019. PMID: 31365035. doi:10.1001/jamadermatol.2019.1946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。